Anlon Healthcare P/E Ratio
Anlon Healthcare (AHCL) P/E ratio is 22.53 (Moderate), EPS (TTM) ₹5.93, current price ₹14.63 on NSE vs historical average P/E of 11.96 (100.0th percentile) — High - Growth expectations or overvalued. Read AHCL ex-dividend dates for the complete payout history and dividend yield track record.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AHCL P/E Ratio — Valuation Signal & Historical Context
Anlon Healthcare P/E 22.53 vs historical average 11.96, range 11.96–11.96 — signal: Overvalued. See AHCL P/B ratio to compare market price against book value per share.
- Current PE is 88.4% above historical average
- Trading at discount to sector average PE of 55.65
Anlon Healthcare P/E Ratio Historical Trend
AHCL annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 22.53 vs historical average 11.96. For live price, revenue and the complete fundamental profile, see AHCL screener.
AHCL Historical P/E Ratio — EPS, Year-End Price & Valuation
Anlon Healthcare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 11.96 | 8.92 | ₹106.64 | NSE | Low |
AHCL vs Healthcare Peers — P/E Ratio Comparison
Anlon Healthcare P/E 22.53 vs Healthcare average 55.65, median 31.02 — range 2.86–712.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.08 | ₹65 | Low |
| Shelter Pharma | SHELTER | 4.85 | ₹44 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| JFL Life Sciences | JFLLIFE | 6.44 | ₹86 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 7.11 | ₹51 | Low |